Related Experiment Video

Updated: May 13, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Forbidden fruit: on the analysis of recurrent events in randomized clinical trials

George A Diamond, Sanjay Kaul

    The American Journal of Cardiology
    |March 5, 2013
    PubMed

    Insights

    Conventional clinical trials often ignore recurrent events, missing crucial data. This study highlights limitations of naive recurrent event analysis and proposes kinetic modeling for comprehensive safety and efficacy insights.

    Area of Science:

    • Clinical Trials
    • Biostatistics
    • Medical Research

    Background:

    • Traditional clinical trial analysis prioritizes the first event in a composite endpoint, excluding subsequent recurrent events.
    • This exclusion leads to incomplete data analysis, potentially overlooking significant trends in patient outcomes.

    Discussion:

    • A naive approach of analyzing all events (first and recurrent) is gaining traction but has significant limitations.
    • This paper critically evaluates the drawbacks of naive recurrent event analysis in clinical trials.
    • Kinetic modeling is proposed as a superior method for analyzing recurrent events.

    Key Insights:

    • Recurrent events in clinical trials provide valuable information often missed by standard analyses.
    • Naive recurrent event analysis can be misleading; a more sophisticated approach is necessary.
    • Kinetic modeling offers a robust framework for understanding event occurrences and underlying mechanisms.

    Outlook:

    • Future clinical trials should incorporate advanced methods like kinetic modeling for recurrent events.
    • This approach can provide deeper insights into drug safety and efficacy by analyzing the full event spectrum.
    • Further research into kinetic modeling applications will enhance clinical trial interpretation and patient care.

    More Related Videos

    A Conflict Model of Reward-seeking Behavior in Male Rats06:11

    A Conflict Model of Reward-seeking Behavior in Male Rats

    Published on: February 20, 2019

    Related Concept Videos

    Hazard Ratio01:12

    Hazard Ratio

    The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
    For example, in a clinical trial evaluating a...
    Clinical Trials01:16

    Clinical Trials

    Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
    There are four phases in a clinical trial. A phase one...
    Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

    Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

    Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
    Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
    Randomized Experiments01:13

    Randomized Experiments

    The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
    Simple randomization
    Simple...
    Clinical Trials: Overview01:11

    Clinical Trials: Overview

    Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
    Blinding01:11

    Blinding

    Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.